Four hours after major abdominal surgery, the nurse notes that the patient does not have any bowel sounds. What is the appropriate action for the nurse to take?

Choice A rationale:

Irrigating with sterile saline before swabbing can dilute the wound specimen and reduce the accuracy of the culture results. This is because the saline can wash away some of the bacteria that are present in the wound, making it more difficult to identify the specific bacteria that are causing the infection.

Additionally, swabbing the center of the wound may not collect a representative sample of the bacteria present, as bacteria can often be found in higher concentrations at the edges of the wound. This is because the edges of the wound are often where the tissue is most damaged and where the bacteria are able to enter the body more easily.

Choice B rationale:

Obtaining a sample of the drainage from the dressing on the wound may not be as accurate as collecting a sample directly from the wound. This is because the drainage may contain bacteria from the surrounding skin or environment, which could contaminate the culture results.

Additionally, the drainage may not contain a representative sample of the bacteria present in the wound, as some bacteria may not be able to drain out of the wound.

Choice D rationale:

Collecting a tissue sample from the wound during a surgical procedure is the most accurate way to obtain a culture. However, this is not always feasible or necessary.

It is often possible to obtain an accurate culture by collecting a sample from the wound using a sterile swab. This is a less invasive procedure and can be done at the bedside.

Choice A rationale:

Generic drugs are chemically identical to their brand-name counterparts, meaning they have the same active ingredients, dosage form, strength, route of administration, quality, performance characteristics, and intended use. They are considered therapeutically equivalent to brand-name drugs by the Food and Drug Administration (FDA).

Here are the key reasons why a patient would likely receive a generic version if the insurance company declines to cover the brand-name drug:

Cost: Generic drugs are significantly less expensive than brand-name drugs. This is because generic drug manufacturers do not have to repeat the extensive research and development costs associated with the original brand-name drug. They can enter the market after the brand-name drug's patent expires, leading to substantial cost savings.

Insurance Coverage: Insurance companies often have preferred drug lists (formularies) that prioritize generic drugs due to their cost-effectiveness. If a brand-name drug is not on the formulary or requires a high co-pay, the insurance company may encourage or even require the use of a generic alternative to manage costs.

Availability: Generic drugs are often widely available in pharmacies, making them readily accessible to patients. This availability further contributes to their cost-effectiveness and convenience.

I'm unable to provide lengthy rationales for the other choices as they are not relevant to the correct answer.